VeriMomБезопасен ли mipa-cocoyl sarcosinate при беременности?
No harmonised reproductive hazard classification (no ECHA Annex VI H360/H361 found) and the Cosmetic Ingredient Review (CIR) safety assessment of sarcosines/sarcosinates concluded these ingredients are 'safe as used' (approved for rinse‑off and limited leave‑on use). No peer‑reviewed evidence of reproductive or developmental toxicity or endocrine disruption specific to cocoyl sarcosinates was identified. Sources: CIR safety assessment (CIR/PubMed) and industry/CosmeticsInfo summary.
Pregnancy-safe products containing mipa-cocoyl sarcosinate
Related ingredients
Frequently asked questions
- Безопасен ли mipa-cocoyl sarcosinate при беременности?
- No harmonised reproductive hazard classification (no ECHA Annex VI H360/H361 found) and the Cosmetic Ingredient Review (CIR) safety assessment of sarcosines/sarcosinates concluded these ingredients are 'safe as used' (approved for rinse‑off and limited leave‑on use). No peer‑reviewed evidence of reproductive or developmental toxicity or endocrine disruption specific to cocoyl sarcosinates was identified. Sources: CIR safety assessment (CIR/PubMed) and industry/CosmeticsInfo summary.
- Безопасен ли mipa-cocoyl sarcosinate при грудном вскармливании?
- Same rationale as pregnancy: no evidence of reproductive/developmental hazard or mechanism suggesting lactation/transfer concerns; CIR concluded sarcosinates are safe as used. No studies showing placental or milk transfer or effects on neonates were found.
- Безопасен ли mipa-cocoyl sarcosinate для кожи малыша?
- No specific developmental/infant toxicity evidence; CIR states sarcosinates are safe in rinse‑off and at limited concentrations in leave‑on use. Dermal absorption data are limited, but sarcosinate surfactants are rinsed and not described as non‑absorbable; per the scoring rules, adult exposure scored 0 and infant exposure increased by +1 because infant skin has higher surface‑area‑to‑weight and an immature barrier. No infant‑specific hazard or mechanism data were found.
- Как VeriMom оценивает mipa-cocoyl sarcosinate?
- VeriMom оценивает mipa-cocoyl sarcosinate в 100/100 (без известных рисков) на основе EU CosIng, классификаций ECHA и исследований PubMed.
- Какие безопасные альтернативы mipa-cocoyl sarcosinate при беременности?
- См. наш список безопасных альтернатив mipa-cocoyl sarcosinate с аналогичной функцией и классификацией без известных рисков.
Проверь любой состав за 2 секунды
Скачай VeriMom бесплатно — отсканируй любой продукт и мгновенно получи оценку безопасности при беременности.
Медицинская оговорка
Данная информация предоставлена исключительно в образовательных целях и не является медицинской рекомендацией. Оценки безопасности основаны на общедоступных данных и могут не отражать все риски. Всегда консультируйтесь с вашим врачом перед использованием любых средств во время беременности или грудного вскармливания.